Results 191 to 200 of about 34,540 (262)

Extracorporeal Shockwave Therapy for Musculoskeletal Pathologies

Veterinary Clinics of North America: Small Animal Practice, 2022
Extracorporeal shockwave therapy has multiple applications in veterinary musculoskeletal pathologies. Primary indications include tendinopathies, malunion fractures, patellar desmitis, and osteoarthritis. There are multiple types of shockwave generators. Current evidence in the canine literature is primarily on electrohydraulic and radial pressure wave
openaire   +4 more sources

Extracorporeal shockwave therapy in calcifying tendinitis of the shoulder

Knee Surgery, Sports Traumatology, Arthroscopy, 2011
AbstractPurposeStrategies for extracorporeal shockwave therapy in calcifying tendinitis of the rotator cuff vary concerning quantity of sessions and doses. The purpose of this prospective pilot study was to determine the difference between the outcome of a single high‐dosage extracorporeal shockwave therapy and two sessions of low‐dosage extracorporeal
Sebastian, Farr   +5 more
openaire   +4 more sources

Extracorporeal Shockwave Therapy

Sports Medicine, 2002
Extracorporeal shockwave therapy (ESWT) has been in use for the treatment of tendinopathies since the early 1990s. The exact mechanism by which ESWT relieves tendon-associated pain is not known; however, there is an increasing body of literature that suggests that it can be an effective therapy for patients who have had repeated nonsurgical treatment ...
Bryan, Chung, J Preston, Wiley
openaire   +2 more sources

EXTRACORPOREAL SHOCKWAVE THERAPY FOR PEYRONIE DISEASE

Archives of Andrology, 2003
While surgery is the mainstay of therapy for Peyronie disease requiring correction of angulation, interest has grown in the application of extracorporeal shockwave therapy (ESWT) as a minimally invasive approach. This article reviews the current literature reporting the use of ESWT for Peyronie disease.
T, Groth, M, Monga
openaire   +2 more sources

Extracorporeal Shockwave Therapy for Interdigital Neuroma

Journal of the American Podiatric Medical Association, 2009
Background: We sought to evaluate the safety and effectiveness of extracorporeal shockwave therapy as a therapeutic treatment for destroying Morton’s neuroma. Methods: Twenty-five patients (25 feet) were included in the study. Indications for participation were more than 8 months of conservative care with a visual analog scale pain score
Lowell Weil   +2 more
openaire   +1 more source

Extracorporeal Shockwave Therapy for Peyronie's Disease: Who Benefits?

Journal of Endourology, 2006
Extracorporeal shockwave therapy (ESWT) has been reported to improve the symptoms of Peyronie's disease. However, the response rates to this treatment appear to be variable. This study aimed to determine whether any patient or plaque characteristics are associated with a better outcome.A series of 36 patients with Peyronie's disease received ESWT as a ...
Joby, Taylor   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy